232 related articles for article (PubMed ID: 30061414)
1. Inhibition of tumor-microenvironment interaction and tumor invasion by small-molecule allosteric inhibitor of DDR2 extracellular domain.
Grither WR; Longmore GD
Proc Natl Acad Sci U S A; 2018 Aug; 115(33):E7786-E7794. PubMed ID: 30061414
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine kinase-independent actions of DDR2 in tumor cells and cancer-associated fibroblasts influence tumor invasion, migration and metastasis.
Barcus CE; Hwang PY; Morikis V; Brenot A; Pence P; Clarke M; Longmore GD
J Cell Sci; 2021 Oct; 134(19):. PubMed ID: 34477203
[TBL] [Abstract][Full Text] [Related]
3. The Action of Discoidin Domain Receptor 2 in Basal Tumor Cells and Stromal Cancer-Associated Fibroblasts Is Critical for Breast Cancer Metastasis.
Corsa CA; Brenot A; Grither WR; Van Hove S; Loza AJ; Zhang K; Ponik SM; Liu Y; DeNardo DG; Eliceiri KW; Keely PJ; Longmore GD
Cell Rep; 2016 Jun; 15(11):2510-23. PubMed ID: 27264173
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal Stem Cell-Induced DDR2 Mediates Stromal-Breast Cancer Interactions and Metastasis Growth.
Gonzalez ME; Martin EE; Anwar T; Arellano-Garcia C; Medhora N; Lama A; Chen YC; Tanager KS; Yoon E; Kidwell KM; Ge C; Franceschi RT; Kleer CG
Cell Rep; 2017 Jan; 18(5):1215-1228. PubMed ID: 28147276
[TBL] [Abstract][Full Text] [Related]
5. TWIST1 induces expression of discoidin domain receptor 2 to promote ovarian cancer metastasis.
Grither WR; Divine LM; Meller EH; Wilke DJ; Desai RA; Loza AJ; Zhao P; Lohrey A; Longmore GD; Fuh KC
Oncogene; 2018 Mar; 37(13):1714-1729. PubMed ID: 29348456
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of discoidin domain receptor 2 reveals kinase-dependent and kinase-independent functions in regulating fibroblast activity.
Ling S; Kwak D; Kim KK
Am J Physiol Lung Cell Mol Physiol; 2023 Sep; 325(3):L342-L351. PubMed ID: 37489274
[TBL] [Abstract][Full Text] [Related]
7. DDR2 controls breast tumor stiffness and metastasis by regulating integrin mediated mechanotransduction in CAFs.
Bayer SV; Grither WR; Brenot A; Hwang PY; Barcus CE; Ernst M; Pence P; Walter C; Pathak A; Longmore GD
Elife; 2019 May; 8():. PubMed ID: 31144616
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of novel dasatinib analogues as potent DDR1 and DDR2 kinase inhibitors.
Liu L; Hussain M; Luo J; Duan A; Chen C; Tu Z; Zhang J
Chem Biol Drug Des; 2017 Mar; 89(3):420-427. PubMed ID: 27589335
[TBL] [Abstract][Full Text] [Related]
9. Integrated Molecular Profiling of Human Gastric Cancer Identifies DDR2 as a Potential Regulator of Peritoneal Dissemination.
Kurashige J; Hasegawa T; Niida A; Sugimachi K; Deng N; Mima K; Uchi R; Sawada G; Takahashi Y; Eguchi H; Inomata M; Kitano S; Fukagawa T; Sasako M; Sasaki H; Sasaki S; Mori M; Yanagihara K; Baba H; Miyano S; Tan P; Mimori K
Sci Rep; 2016 Mar; 6():22371. PubMed ID: 26934957
[TBL] [Abstract][Full Text] [Related]
10. Parity predisposes breasts to the oncogenic action of PAPP-A and activation of the collagen receptor DDR2.
Slocum E; Craig A; Villanueva A; Germain D
Breast Cancer Res; 2019 May; 21(1):56. PubMed ID: 31046834
[TBL] [Abstract][Full Text] [Related]
11. The Journey of DDR1 and DDR2 Kinase Inhibitors as Rising Stars in the Fight Against Cancer.
Elkamhawy A; Lu Q; Nada H; Woo J; Quan G; Lee K
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207360
[TBL] [Abstract][Full Text] [Related]
12. DDR2 upregulation confers ferroptosis susceptibility of recurrent breast tumors through the Hippo pathway.
Lin CC; Yang WH; Lin YT; Tang X; Chen PH; Ding CC; Qu DC; Alvarez JV; Chi JT
Oncogene; 2021 Mar; 40(11):2018-2034. PubMed ID: 33603168
[TBL] [Abstract][Full Text] [Related]
13. Discoidin Domain Receptor 2 Expression as Worse Prognostic Marker in Invasive Breast Cancer.
Romayor I; García-Vaquero ML; Márquez J; Arteta B; Barceló R; Benedicto A
Breast J; 2022; 2022():5169405. PubMed ID: 35711892
[TBL] [Abstract][Full Text] [Related]
14. DDR2 inhibition reduces migration and invasion of murine metastatic melanoma cells by suppressing MMP2/9 expression through ERK/NF-κB pathway.
Poudel B; Lee YM; Kim DK
Acta Biochim Biophys Sin (Shanghai); 2015 Apr; 47(4):292-8. PubMed ID: 25733533
[TBL] [Abstract][Full Text] [Related]
15. A host deficiency of discoidin domain receptor 2 (DDR2) inhibits both tumour angiogenesis and metastasis.
Zhang S; Bu X; Zhao H; Yu J; Wang Y; Li D; Zhu C; Zhu T; Ren T; Liu X; Yao L; Su J
J Pathol; 2014 Mar; 232(4):436-48. PubMed ID: 24293323
[TBL] [Abstract][Full Text] [Related]
16. DDR2-regulated arginase activity in ovarian cancer-associated fibroblasts promotes collagen production and tumor progression.
Akinjiyan FA; Ibitoye Z; Zhao P; Shriver LP; Patti GJ; Longmore GD; Fuh KC
Oncogene; 2024 Jan; 43(3):189-201. PubMed ID: 37996700
[TBL] [Abstract][Full Text] [Related]
17. Incorporation of DDR2 clusters into collagen matrix via integrin-dependent posterior remnant tethering.
Li T; Liu J; Cai H; Wang B; Feng Y; Liu J
Int J Biol Sci; 2018; 14(6):654-666. PubMed ID: 29904280
[TBL] [Abstract][Full Text] [Related]
18. Spatial localisation of Discoidin Domain Receptor 2 (DDR2) signalling is dependent on its collagen binding and kinase activity.
Luczynski MT; Harrison PT; Lima N; Krasny L; Paul A; Huang PH
Biochem Biophys Res Commun; 2018 Jun; 501(1):124-130. PubMed ID: 29709482
[TBL] [Abstract][Full Text] [Related]
19. Discoidin domain receptor 2 (DDR2) promotes breast cancer cell metastasis and the mechanism implicates epithelial-mesenchymal transition programme under hypoxia.
Ren T; Zhang W; Liu X; Zhao H; Zhang J; Zhang J; Li X; Zhang Y; Bu X; Shi M; Yao L; Su J
J Pathol; 2014 Dec; 234(4):526-37. PubMed ID: 25130389
[TBL] [Abstract][Full Text] [Related]
20. Discoidin Domain Receptor 2 Signaling Regulates Fibroblast Apoptosis through PDK1/Akt.
Jia S; Agarwal M; Yang J; Horowitz JC; White ES; Kim KK
Am J Respir Cell Mol Biol; 2018 Sep; 59(3):295-305. PubMed ID: 29652518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
